{
    "organizations": [],
    "uuid": "622d6f5719609d83c6c356799771ba3dd9a75166",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cti-biopharma-provides-corporate-a/brief-cti-biopharma-provides-corporate-and-european-regulatory-update-idUSASB0C2HY",
    "ord_in_thread": 0,
    "title": "BRIEF-CTI Biopharma Provides Corporate And European Regulatory Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - CTI Biopharma Corp:\n* CTI BIOPHARMA PROVIDES CORPORATE AND EUROPEAN REGULATORY UPDATE\n* CTI BIOPHARMA - WAS GRANTED 3 MONTH EXTENSION TO SUBMIT ITS RESPONSE TO DAY 120 LIST OF QUESTIONS FOR HUMAN USE OF EMA, REGARD TO MAA FOR PACRITINIB\n* CTI BIOPHARMA CORP - CO ANTICIPATES SUBMITTING ITS RESPONSE TO D120 LOQ IN MAY 2018\n* CTI BIOPHARMA CORP - CO REINCORPORATED IN STATE OF DELAWARE, DELISTED FROM BORSA ITALIANA MTA EXCHANGE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-26T05:55:00.000+02:00",
    "crawled": "2018-01-26T21:30:42.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "cti",
        "biopharma",
        "corp",
        "cti",
        "biopharma",
        "provides",
        "corporate",
        "european",
        "regulatory",
        "update",
        "cti",
        "biopharma",
        "granted",
        "month",
        "extension",
        "submit",
        "response",
        "day",
        "list",
        "question",
        "human",
        "use",
        "ema",
        "regard",
        "maa",
        "pacritinib",
        "cti",
        "biopharma",
        "corp",
        "co",
        "anticipates",
        "submitting",
        "response",
        "d120",
        "loq",
        "may",
        "cti",
        "biopharma",
        "corp",
        "co",
        "reincorporated",
        "state",
        "delaware",
        "delisted",
        "borsa",
        "italiana",
        "mta",
        "exchange",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}